Blog Posts by Tag: Laboratory
Streamlining Diagnostic Processes: How Dolbey Fusion Narrate Integrates with XIFIN LIS
Enjoy the following content from our partner, Dolbey. Thousands – or even millions – of data points can be recorded in and referenced from an LIS, but moving back and forth between the LIS and lab tests can drag down your productivity. With speech recognition, you can reference and record information in an LIS without a mouse and keyboard. One of the most powerful laboratory information...
XIFIN Launches XIFIN LIS 7 and Announces a New Strategic Partnership with Dolbey
The COVID-19 pandemic has created a tremendous uptick in diagnostic testing. The significant drop in routine test volume experienced in late March through April that was due to the COVID-19 pandemic has for the most part recovered, and the addition of COVID testing has pushed clinical laboratory test volumes well above traditional levels. This means lab leaders need new capabilities and...
How AI Can Optimize the Laboratory Revenue Payment Lifecycle
Enjoy the following content from our partner, Infinx. Maximizing revenue in the laboratory healthcare industry’s complex third-party payer system has always been a challenge. With increasingly elaborate payment models and escalating payer scrutiny for high-tech testing, it’s never been more critical to stay current with new technological advances in the revenue payment lifecycle.For our...
Balancing the 4 C’s of Laboratory Information Systems – Cost, Complexity, Control, and Change
Deciding which LIS is best suited to meet the needs of your laboratory today and in the future is an important decision with several factors to be considered. No LIS is fully “plug-and-play”; some configuration is always required. The question is how much, and whether it is implemented with the tools and templates provided by the software vendor, in order to avoid becoming a one-off...
2021 CMS Proposed Medicare Physician Fee Schedule Released
On August 4, 2020 CMS released its 2021 proposed physician fee schedule. Unfortunately, under the proposed schedule, pathology and several other specialties would take the brunt of some significant reductions. This is largely the result of the redistributive effects of previously finalized changes to the office/outpatient E/M visits taking effect in 2021. The results of these reductions will have...
Is the FDA on a Dangerous Path? Overstepping LDT Authority Hampered COVID Response and Has Long Term Consequences for US Healthcare
As I recently discussed during my session at this year’s Executive War College, one important aspect of the COVID pandemic and laboratory testing during this time is how it exemplified the detrimental consequences of FDA overreach — which contributed in large part to testing delays and a hamstrung response in the outbreak’s early days — and how that overstepping poses risk going forward. On...
G0416 Prostate Update for Cigna: Go-Live August 18, 2020
As announced by Cigna earlier this summer, beginning August 18, 2020 Cigna will require pathology groups to submit G0416 for prostate needle biopsies instead of 88305. Prostate biopsies will no longer be reimbursed using the 88305.XIFIN confirmed with Cigna that this applies to all Cigna plans, not just a select few. Commercial payors aligning with CMS guidelines on G codes is becoming a trend...
Selecting a Purpose-Built Lab RCM and Service Is the Right First Step ― But They’re Not All Equal
Over the past year, leading global IT research and advisory firm, International Data Corporation (IDC) published a paper and participated in a webinar discussing the benefits for hospitals and health system laboratories in choosing purpose-built revenue cycle management (RCM) systems. In the IDC paper, research director Mutaz Shegewi examines the specific benefits for hospitals and health systems...
- 1 of 12
- next ›